Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05675319 |
|---|---|
| Brief Title: | Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy (AlloRelapseMM) |
| First Submitted : | November 6, 2022 |
| First Submitted that Met QC Criteria : | January 5, 2023 |
| First Posted : | January 9, 2023 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |